{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:12Z","timestamp":1790803272130,"version":"4.1.0"},"reference-count":80,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Landiolol is an ultra-short-acting, selective \u03b21-adrenergic receptor blocker that was originally approved in Japan for the treatment of intraoperative tachyarrhythmias. It has gained attention for its use in the management of tachyarrhythmias and perioperative tachycardia, especially atrial fibrillation for both cardiac and non-cardiac surgeries. It can be the ideal agent for heart rate control due to its high \u03b21-selectivity, potent negative chronotropic effect, a limited negative inotropic potential, and an ultrashort elimination half-life (around 4 min); moreover, it may have a potential therapeutic effects for sepsis and pediatric patients. Landiolol seems to be superior to other short-acting and selective beta-blockers such as esmolol. This review aims to provide a comprehensive overview of landiolol, a new ultra-short-acting \u03b21 selective antagonist, including its pharmacology, clinical applications, efficacy, safety profile, and future directions in research and clinical data.<\/jats:p>","DOI":"10.3390\/pharmaceutics16040517","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T10:11:55Z","timestamp":1712571115000},"page":"517","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting \u03b21 Selective Antagonist) in Atrial Fibrillation"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-1503","authenticated-orcid":false,"given":"Mariana","family":"Floria","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-4562","authenticated-orcid":false,"given":"Alexandru Florinel","family":"Oancea","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Cristina","family":"Morariu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-1588","authenticated-orcid":false,"given":"Alexandru","family":"Burlacu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Cardiovascular Disease Institute, 700503 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Elena","family":"Iov","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Petronela","family":"Chiriac","sequence":"additional","affiliation":[{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genoveva Livia","family":"Baroi","sequence":"additional","affiliation":[{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"},{"name":"Department of Surgery, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-4349","authenticated-orcid":false,"given":"Celina Silvia","family":"Stafie","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-0967","authenticated-orcid":false,"given":"Magdalena","family":"Cuciureanu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel","family":"Scripcariu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Regional Institute of Oncology, 700483 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-2506","authenticated-orcid":false,"given":"Daniela Maria","family":"Tanase","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Oancea, A.F., Jigoranu, R.A., Morariu, P.C., Miftode, R.-S., Trandabat, B.A., Iov, D.E., Cojocaru, E., Costache, I.I., Baroi, L.G., and Timofte, D.V. (2023). Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle. Life, 13.","DOI":"10.3390\/life13061370"},{"key":"ref_2","first-page":"339","article-title":"Effect of Landiolol for Atrial Fibrillation after Open Heart Surgery","volume":"75","author":"Kawakami","year":"2023","journal-title":"Jpn. J. Thorac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1067\/mcp.2000.108733","article-title":"Pharmacokinetics of Landiolol Hydrochloride, a New Ultra-Short-Acting \u03b2-Blocker, in Patients with Cardiac Arrhythmias","volume":"68","author":"Atarashi","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00228-016-2176-0","article-title":"Bolus Application of Landiolol and Esmolol: Comparison of the Pharmacokinetic and Pharmacodynamic Profiles in a Healthy Caucasian Group","volume":"73","author":"Krumpl","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1213\/01.ane.0000249044.40819.e5","article-title":"The Hemodynamic Effects of Landiolol, an Ultra-Short-Acting \u03b21-Selective Blocker, on Endotracheal Intubation in Patients with and without Hypertension","volume":"104","author":"Sugiura","year":"2007","journal-title":"Anesth. Analg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12325-014-0111-2","article-title":"Impacts of patient characteristics on the effectiveness of landiolol in AF\/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study","volume":"31","author":"Kinugawa","year":"2014","journal-title":"Adv. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphar.2013.00150","article-title":"Characteristic Interactivity of Landiolol, an Ultra-Short-Acting Highly Selective \u03921-Blocker, with Biomimetic Membranes: Comparisons with \u03921-Selective Esmolol and Non-Selective Propranolol and Alprenolol","volume":"4","author":"Tsuchiya","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/joa3.12934","article-title":"Landiolol, an Intravenous \u03921-selective Blocker, Is Useful for Dissociating a Fusion of Atrial Activation via Accessory Pathway and Atrioventricular Node","volume":"39","author":"Kinjo","year":"2023","journal-title":"J. Arrhythm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.116.232884","article-title":"Comparison of the -Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions","volume":"359","author":"Sucic","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3164\/jcbn.21-157","article-title":"Dose-Dependent Scavenging Activity of the Ultra-Short-Acting \u03921-Blocker Landiolol against Specific Free Radicals","volume":"71","author":"Matsumoto","year":"2022","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40265-013-0077-4","article-title":"Landiolol: A review of its use in intraoperative and postoperative tachyarrhythmias","volume":"73","author":"Plosker","year":"2013","journal-title":"Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00540-008-0640-4","article-title":"Landiolol Has a Less Potent Negative Inotropic Effect than Esmolol in Isolated Rabbit Hearts","volume":"22","author":"Ikeshita","year":"2008","journal-title":"J. Anesth."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/VHRM.S210561","article-title":"Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature","volume":"16","author":"Matsuishi","year":"2020","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00595-013-0616-3","article-title":"Atrial Fibrillation after Esophageal Cancer Surgery: An Analysis of 207 Consecutive Patients","volume":"44","author":"Ojima","year":"2014","journal-title":"Surg. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00540-007-0558-2","article-title":"Cardioprotective Effect and Mechanism of Action of Landiolol on the Ischemic Reperfused Heart","volume":"21","author":"Kanaya","year":"2007","journal-title":"J. Anesth."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12325-014-0116-x","article-title":"Perioperative Landiolol Administration Reduces Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials","volume":"31","author":"Sakamoto","year":"2014","journal-title":"Adv. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2133\/dmpk.20.337","article-title":"Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra Short-Acting \u03921-Selective Blocker, in a Dose Escalation Regimen in Healthy Male Volunteers","volume":"20","author":"Murakami","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2016.07.076","article-title":"Beneficial Effect of Early Infusion of Landiolol, a Very Short-Acting Beta-1 Adrenergic Receptor Blocker, on Reperfusion Status in Acute Myocardial Infarction","volume":"221","author":"Kiyokuni","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jjcc.2012.06.010","article-title":"Acute Hemodynamic Effects of Landiolol, an Ultra-Short-Acting Beta-Blocker, in Patients with Acute Coronary Syndrome: Preliminary Study","volume":"60","author":"Hoshi","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of Heart Rate Control with Esmolol on Hemodynamic and Clinical Outcomes in Patients with Septic Shock","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lfs.2014.04.005","article-title":"Significant Reversal of Cardiac Upregulated Endothelin-1 System in a Rat Model of Sepsis by Landiolol Hydrochloride","volume":"118","author":"Seki","year":"2014","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ehf2.14202","article-title":"Heart Rate Control with Landiolol Hydrochloride in Infants with Ventricular Dysfunction and Pulmonary Hypertension","volume":"10","author":"Schroeder","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00228-023-03584-3","article-title":"Mechanisms of Landiolol-Mediated Positive Inotropy in Critical Care Settings","volume":"79","author":"Chalkias","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.recesp.2019.02.023","article-title":"Beta-Blockers: Historical Perspective and Mechanisms of Action","volume":"72","author":"Oliver","year":"2019","journal-title":"Rev. Espa\u00f1ola Cardiol. (Engl. Ed.)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"104274","DOI":"10.1016\/j.phrs.2019.104274","article-title":"Antiarrhythmic Mechanisms of Beta Blocker Therapy","volume":"146","author":"Grandi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/j.jvca.2017.11.039","article-title":"Ultra-Short\u2013Acting \u03b2-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients","volume":"32","author":"Monaco","year":"2018","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_27","unstructured":"Morris, J., Awosika, A.O., and Dunham, A. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10557-021-07205-y","article-title":"Therapeutic Properties of Highly Selective \u03b2-Blockers with or without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients with Cardiovascular Disease","volume":"36","author":"AlHabeeb","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03188723","article-title":"Clinical Pharmacokinetics of Atenolol\u2014A Review","volume":"7","author":"Kirch","year":"1982","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A Unique Mechanism of \u03b2-Blocker Action: Carvedilol Stimulates \u03b2-Arrestin Signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(76)90904-9","article-title":"The Essential Action of Propranolol in Hypertension","volume":"60","author":"Lewis","year":"1976","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtcvs.2015.07.003","article-title":"Safety and Efficacy of Landiolol Hydrochloride for Prevention of Atrial Fibrillation after Cardiac Surgery in Patients with Left Ventricular Dysfunction: Prevention of Atrial Fibrillation after Cardiac Surgery with Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) Trial","volume":"150","author":"Sezai","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jtcvs.2010.10.045","article-title":"Landiolol Hydrochloride for Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting: New Evidence from the PASCAL Trial","volume":"141","author":"Sezai","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jtcvs.2012.06.042","article-title":"Feasibility of Landiolol and Bisoprolol for Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting: A Pilot Study","volume":"144","author":"Sezai","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/SHK.0b013e3181863689","article-title":"Landiolol, an Ultrashort-Acting \u03b21-Adrenoceptor Antagonist, Has Protective Effects in an Lps-Induced Systemic Inflammation Model","volume":"31","author":"Hagiwara","year":"2009","journal-title":"Shock"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.jvca.2018.04.045","article-title":"Perioperative \u03b2-Adrenergic Blockade in Noncardiac and Cardiac Surgery: A Clinical Update","volume":"33","author":"Oprea","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients with Atrial Fibrillation: Executive Summary","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_39","first-page":"CD003611","article-title":"Interventions for Preventing Post-Operative Atrial Fibrillation in Patients Undergoing Heart Surgery","volume":"2013","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.hlc.2017.08.026","article-title":"Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis","volume":"27","author":"Thein","year":"2018","journal-title":"Heart Lung Circ."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"A4","DOI":"10.1093\/eurheartj\/sux038","article-title":"Landiolol for Managing Atrial Fibrillation in Post-Cardiac Surgery","volume":"20","author":"Fellahi","year":"2018","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s11748-020-01364-9","article-title":"Preventive Effect of Low-Dose Landiolol on Postoperative Atrial Fibrillation Study (PELTA Study)","volume":"68","author":"Sasaki","year":"2020","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5761\/atcs.ra.21-00126","article-title":"Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis","volume":"28","author":"Hao","year":"2022","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1253\/circj.CJ-11-1332","article-title":"Landiolol, an Ultra-Short-Acting \u03921-Blocker, More Effectively Terminates Atrial Fibrillation than Diltiazem after Open Heart Surgery: Prospective, Multicenter, Randomized, Open-Label Study (JL-KNIGHT Study)","volume":"76","author":"Sakamoto","year":"2012","journal-title":"Circ. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11845-016-1447-1","article-title":"Are Beta-Blockers Effective for Preventing Post-Coronary Artery Bypass Grafting Atrial Fibrillation? Direct and Network Meta-Analyses","volume":"185","author":"Ji","year":"2016","journal-title":"Ir. J. Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0029-1186069","article-title":"Postoperative Treatment of Carvedilol Following Low Dose Landiolol Has Preventive Effect for Atrial Fibrillation after Coronary Artery Bypass Grafting","volume":"57","author":"Yoshioka","year":"2009","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1093\/eurheartj\/sux036","article-title":"Landiolol for Managing Post-Operative Atrial Fibrillation","volume":"20","author":"Balik","year":"2018","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2710.2011.01315.x","article-title":"Effect of Landiolol Hydrochloride, an Ultra-Short-Acting Beta 1-Selective Blocker, on Supraventricular Tachycardia, Atrial Fibrillation and Flutter after Pulmonary Resection","volume":"37","author":"Nakano","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s11748-011-0841-x","article-title":"Efficacy of Low-Dose Landiolol, an Ultrashort-Acting \u03b2-Blocker, on Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer","volume":"59","author":"Nojiri","year":"2011","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4236\/ojanes.2014.48026","article-title":"Safety of Landiolol Infusion in Patients Undergoing Lung Resection","volume":"4","author":"Ito","year":"2014","journal-title":"Open J. Anesthesiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11748-016-0707-3","article-title":"Landiolol Infusion during General Anesthesia Does Not Prevent Postoperative Atrial Fibrillation in Patients Undergoing Lung Resection","volume":"64","author":"Aoyama","year":"2016","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10388-016-0553-5","article-title":"A Randomized, Open Label Study of the Efficacy of Prophylactic 24-h Low-Dose Landiolol for Atrial Fibrillation in Transthoracic Esophagectomy","volume":"14","author":"Yoshida","year":"2017","journal-title":"Esophagus"},{"key":"ref_53","first-page":"953","article-title":"Use of Landiolol Hydrochloride for the Prevention of Atrial Fibrillation after Lung Resection","volume":"57","author":"Okita","year":"2008","journal-title":"Masui"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00595-013-0615-4","article-title":"Landiolol Hydrochloride for Early Postoperative Tachycardia after Transthoracic Esophagectomy","volume":"44","author":"Mori","year":"2014","journal-title":"Surg. Today"},{"key":"ref_55","first-page":"1546","article-title":"Effect of Landiolol Hydrochloride on Tachyarrhythmia after Esophagectomy","volume":"61","author":"Niwa","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1510\/icvts.2009.212837","article-title":"Postoperative Administration of Landiolol Hydrochloride for Patients with Supraventricular Arrhythmia: The Efficacy of Sustained Intravenous Infusion at a Low Dose","volume":"9","author":"Wariishi","year":"2009","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/bjs.10548","article-title":"Randomized Clinical Trial of Landiolol Hydrochloride for the Prevention of Atrial Fibrillation and Postoperative Complications after Oesophagectomy for Cancer","volume":"104","author":"Ojima","year":"2017","journal-title":"Br. J. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1093\/eurheartjsupp\/suac024","article-title":"The Role of Landiolol in the Management of Atrial Tachyarrhythmias in Patients with Acute Heart Failure and Cardiogenic Shock: Case Reports and Review of Literature","volume":"24","author":"Bezati","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5492\/wjccm.v4.i3.251","article-title":"Landiolol, an Ultra-Short-Acting \u03921-Blocker, Is Useful for Managing Supraventricular Tachyarrhythmias in Sepsis","volume":"4","author":"Okajima","year":"2015","journal-title":"World J. Crit. Care Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1093\/eurheartj\/sux039","article-title":"Landiolol for Managing Atrial Fibrillation in Intensive Care","volume":"20","author":"Rehberg","year":"2018","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","article-title":"Urgent Management of Rapid Heart Rate in Patients with Atrial Fibrillation\/Flutter and Left Ventricular Dysfunction\u2014Comparison of the Ultra-Short-Acting \u03921-Selective Blocker Landiolol with Digoxin (J-Land Study)","volume":"77","author":"Nagai","year":"2013","journal-title":"Circ. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.joa.2015.09.002","article-title":"Practical Applicability of Landiolol, an Ultra-Short-Acting \u03921-Selective Blocker, for Rapid Atrial and Ventricular Tachyarrhythmias with Left Ventricular Dysfunction","volume":"32","author":"Wada","year":"2016","journal-title":"J. Arrhythm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1253\/circrep.CR-19-0076","article-title":"Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients with Acute Decompensated Heart Failure with Severely Reduced Ejection Fraction","volume":"1","author":"Iwahashi","year":"2019","journal-title":"Circ. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000499400","article-title":"Addition of a \u03921-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation","volume":"142","author":"Kobayashi","year":"2019","journal-title":"Cardiology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and Safety of Landiolol, an Ultra-Short-Acting \u03921-Selective Antagonist, for Treatment of Sepsis-Related Tachyarrhythmia (J-Land 3S): A Multicentre, Open-Label, Randomised Controlled Trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100571","DOI":"10.1016\/j.eclinm.2020.100571","article-title":"Impact of Patient Characteristics on the Efficacy and Safety of Landiolol in Patients with Sepsis-Related Tachyarrhythmia: Subanalysis of the J-Land 3S Randomised Controlled Study","volume":"28","author":"Matsuda","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s13063-018-3024-6","article-title":"Landiolol in Patients with Septic Shock Resident in an Intensive Care Unit (LANDI-SEP): Study Protocol for a Randomized Controlled Trial","volume":"19","author":"Unger","year":"2018","journal-title":"Trials"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jointm.2022.01.004","article-title":"Beta-Blockers in Septic Shock: What Is New?","volume":"2","author":"Lescroart","year":"2022","journal-title":"J. Intensive Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","article-title":"Infusion of the \u03b2-Adrenergic Blocker Esmolol Attenuates Myocardial Dysfunction in Septic Rats","volume":"33","author":"Suzuki","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00134-011-2236-y","article-title":"Effects of Esmolol on Systemic and Pulmonary Hemodynamics and on Oxygenation in Pigs with Hypodynamic Endotoxin Shock","volume":"37","author":"Aboab","year":"2011","journal-title":"Intensive Care Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/CCM.0000000000001078","article-title":"\u03921-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock","volume":"43","author":"Kimmoun","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-018-0883-9","article-title":"Landiolol: A Review in Tachyarrhythmias","volume":"78","author":"Syed","year":"2018","journal-title":"Drugs"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jjcc.2019.05.012","article-title":"A Prospective Observational Survey on Landiolol in Atrial Fibrillation\/Atrial Flutter Patients with Chronic Heart Failure\u2014AF-CHF Landiolol Survey","volume":"74","author":"Yamashita","year":"2019","journal-title":"J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jjcc.2014.09.008","article-title":"Design of a Prospective Observational Survey on Landiolol in Atrial Fibrillation\/Atrial Flutter Patients with Chronic Heart Failure\u2014AF-CHF Landiolol Survey","volume":"66","author":"Yamashita","year":"2015","journal-title":"J. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1253\/circj.CJ-19-0661","article-title":"Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation\/Atrial Flutter in Caucasian Patients","volume":"84","author":"Stix","year":"2019","journal-title":"Circ. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.jvca.2015.09.007","article-title":"Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients","volume":"30","author":"Shibata","year":"2016","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jclinane.2017.01.036","article-title":"The Suppressive Effects of Landiolol Administration on the Occurrence of Postoperative Atrial Fibrillation and Tachycardia, and Plasma IL-6 Elevation in Patients Undergoing Esophageal Surgery: A Randomized Controlled Clinical Trial","volume":"38","author":"Horikoshi","year":"2017","journal-title":"J. Clin. Anesth."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Schnaubelt, S., Eibensteiner, F., Oppenauer, J., Tihanyi, D., Neymayer, M., Brock, R., Kornfehl, A., Veigl, C., Al Jalali, V., and Anders, S. (2023). Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care\u2014A Retrospective Cross-Sectional Study. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020134"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lfs.2016.10.010","article-title":"Landiolol Hydrochloride Ameliorates Acute Lung Injury in a Rat Model of Early Sepsis through the Suppression of Elevated Levels of Pulmonary Endothelin-1","volume":"166","author":"Matsuishi","year":"2016","journal-title":"Life Sci."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/4\/517\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:00Z","timestamp":1760106300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/4\/517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["pharmaceutics16040517"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16040517","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}